Literature DB >> 7104144

Effects of propranolol and pindolol on plasma lignocaine clearance in man.

T L Svendsen, M Tangø, S Waldorff, E Steiness, J Trap-Jensen.   

Abstract

1 Steady state concentrations and clearance of lignocaine were determine in eight healthy volunteers during 360 min continuous lignocaine infusion (2 mg/min). Before the infusion propranolol (0.18 mg/kg i.v.), pindolol (0.023 mg/kg i.v.) or placebo were administered in a random double-blind, cross over design. 2 During the infusion of lignocaine heart rate, cardiac output and arterial blood pressure were measured every 60 min. 3 Propranolol decreased heart rate and cardiac output significantly by 10--20%, while pindolol or lignocaine did not change cardiac output or heart rate significantly. None of the drugs changed the arterial blood pressure. 4 Propranolol pretreatment decreased lignocaine significantly by 14.7% and the steady state concentration was increased by 22.5%. Pindolol produced no significant change in steady state concentration or clearance of lignocaine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7104144      PMCID: PMC1402146          DOI: 10.1111/j.1365-2125.1982.tb01915.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.

Authors:  T L Svendsen; O Hartling; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

Review 2.  Hemodynamic drug interactions.

Authors:  A S Nies; D G Shand; R A Branch
Journal:  Cardiovasc Clin       Date:  1974

3.  Control of the splanchnic circulation in man. Role of beta-adrenergic receptors.

Authors:  H L Price; L H Cooperman; J C Warden
Journal:  Circ Res       Date:  1967-09       Impact factor: 17.367

4.  Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans.

Authors:  P D Thomson; K L Melmon; J A Richardson; K Cohn; W Steinbrunn; R Cudihee; M Rowland
Journal:  Ann Intern Med       Date:  1973-04       Impact factor: 25.391

5.  Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man.

Authors:  R E Stenson; R T Constantino; D C Harrison
Journal:  Circulation       Date:  1971-02       Impact factor: 29.690

6.  Adrenergic beta receptor blockade: hemodynamic importance of intrinsic sympathomimetic activity at rest.

Authors:  T L Svendsen; O J Hartling; J Trap-Jensen; A McNair; J Bliddal
Journal:  Clin Pharmacol Ther       Date:  1981-06       Impact factor: 6.875

7.  Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol.

Authors:  H R Ochs; G Carstens; D J Greenblatt
Journal:  N Engl J Med       Date:  1980-08-14       Impact factor: 91.245

8.  A comparison of the acute haemodynamic effects of propranolol and pindolol at rest and during supine exercise in man.

Authors:  T L Svendsen; J E Carlsen; O Hartling; A McNair; J Trap-Jensen
Journal:  Clin Sci (Lond)       Date:  1980-12       Impact factor: 6.124

  8 in total
  7 in total

Review 1.  beta-blockers. Drug interactions of clinical significance.

Authors:  I Blaufarb; T M Pfeifer; W H Frishman
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Effect of beta-adrenergic blockade on hormonal responses during continuous and intermittent exercise.

Authors:  L Gullestad; L O Dolva; S E Kjeldsen; I Eide; J Kjekshus
Journal:  Cardiovasc Drugs Ther       Date:  1989-03       Impact factor: 3.727

3.  Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine.

Authors:  G T Tucker; N D Bax; M S Lennard; S Al-Asady; H S Bharaj; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

4.  How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

5.  The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.

Authors:  N D Bax; G T Tucker; M S Lennard; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

Review 6.  Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide.

Authors:  C P Denaro; N L Benowitz
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

Review 7.  The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.

Authors:  S Nattel; G Gagne; M Pineau
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.